Biomarker opens office in BioPartner Center Maastricht
ACS Biomarker b.v. develops
and commercializes cardiovascular biomarkers discovered at the Cardiovascular
Research Institute of Maastricht University (CARIM). ACS Biomarker draws
upon a unique large scale lead-identification strategy to identify novel
markers to serve as molecular probes of early vascular and cardiac disease.
ACS Biomarker aims to be the first in delivering clinical proof for
novel biomarkers that can help the physician to recognize disease before
their patient does.